1992Diploma-thesis at the Institute of Biochemistry, Johannes Gutenberg University, Mainz, Germany, under the leadership of Prof. K. Dose
1992-1995PhD (Dr. rer. nat.) at the Institute of Biochemistry, Johannes Gutenberg University, Mainz, Germany, under the leadership of Prof. K. Dose
1995-1996Postdoc-fellowship from the German academical exchange service (DAAD) Laboratory of Prof. R. A. Capaldi, Institute of Molecular Biology, Eugene, U. S. A.
1996-1997Research Associate at the Institute of Molecular Biology, Eugene, U.S.A.; Laboratory of Prof. R. A. Capaldi and Prof. B. W. Matthews
1997-1999HFSP-Fellow, University of Osnabrück, Germany
2001Habilitation-Fellow of the Deutschen Forschungsgemeinschaft (DFG) at the University of Osnabrück, GermanyHabilitation (Dr. habil. in Biochemistry) at the University of Osnabrück, Germany
2001-2005Group Leader at the Institute of Biophysics, University of the Saarland, Homburg (Saar), Germany
2002Habilitation in the section Biochemistry at the University of the Saarland, Homburg (Saar), Germany
2005-2011Associate Professor with tenure at the School of Biological Sciences (SBS), Nanyang Technological University (NTU), Singapore
2011-present Professor with tenure at the School of Biological Sciences, NTU
2007-2011Deputy Head of the Division of Structural and Computational Biology, SBS, NTU, Singapore
2009-presentAdjunct Member of the Bioinformatics Institute, A*STAR, Singapore
2010-2011Acting Associate Chair (Research and Graduate Studies), School of Biological Sciences, NTU
2011-2014Associate Chair (Research and Graduate Studies), School of Biological Sciences, NTU
2017-2022Lead PI of the NRF Competitive Research Programme (CRP) excellence cluster TOPNet (Targeting Oxidative Phosphorylation for the Rational Development of Sterilising Drug Combination for Drug-resistant Tuberculosis)
2018-2022Senator of the 6th and 7th Senate of Nanyang Technological University Singapore (NTU)
2022-2027Lead PI of the NRF CRP excellence cluster TELMabNet (Targeting Energy of Life for the Development of Drug Combination to Eradicate Antibiotic-tolerant Mycobacterium abscessus, a Clinical Nightmare)
